Survival Analysis

"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.

Descriptor ID	D016019
MeSH Number(s)	E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
Concept/Terms	Survival Analysis Survival Analysis Analysis, Survival Analyses, Survival Survival Analyses

Below are MeSH descriptors whose meaning is more general than "Survival Analysis".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Statistics as Topic [E05.318.740]
Survival Analysis [E05.318.740.998]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Statistics as Topic [N05.715.360.750]
Survival Analysis [N05.715.360.750.795]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Statistics as Topic [N06.850.520.830]
Survival Analysis [N06.850.520.830.998]

Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.

Bar chart showing 448 publications over 30 distinct years, with a maximum of 31 publications in 2009

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	3	3
1996	0	3	3
1997	0	3	3
1998	0	5	5
1999	1	8	9
2000	1	10	11
2001	0	13	13
2002	1	14	15
2003	0	14	14
2004	0	24	24
2005	0	18	18
2006	0	17	17
2007	0	20	20
2008	0	22	22
2009	1	30	31
2010	0	26	26
2011	0	16	16
2012	0	22	22
2013	1	20	21
2014	0	22	22
2015	1	23	24
2016	1	24	25
2017	1	19	20
2018	0	20	20
2019	1	16	17
2020	0	14	14
2021	0	7	7
2022	0	3	3
2023	0	2	2
2024	0	1	1

Below are the most recent publications written about "Survival Analysis" by people in Profiles.

Pugashetti JV, Kim JS, Bose S, Adegunsoye A, Linderholm AL, Chen CH, Strek ME, Flaherty KR, Murray S, Newton CA, Alqalyoobi S, Ma SF, Mychaleckyj JC, Bowler RP, Han MK, Curtis JL, Martinez FJ, Smith JA, Noth I, Oldham JM. Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. Am J Respir Crit Care Med. 2024 Sep 01; 210(5):639-647.

View in: PubMed
Kim DY, Dee EC, Cheng I, Hartman RI. Advanced melanoma presentation and disease-specific survival disparities among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations. J Am Acad Dermatol. 2024 03; 90(3):623-626.

View in: PubMed
Romatoski KS, Chung SH, de Geus SWL, Papageorge MV, Woods AP, Rasic G, Ng SC, Tseng JF, Sachs TE. Combined High-Volume Common Complex Cancer Operations Safeguard Long-Term Survival in a Low-Volume Individual Cancer Operation Setting. Ann Surg Oncol. 2023 Sep; 30(9):5352-5360.

View in: PubMed
Tucker SM, Zaihra T. Cytogenetic and survival analysis in 315 multiple myeloma patients; five with orbital and eight with extramedullary disease. Orbit. 2023 Dec; 42(6):603-611.

View in: PubMed
Santoni M, Molina-Cerrillo J, Massari F, Montironi R, Grande E. Re: Effect of Immunotherapy Time-of-day Infusion on Overall Survival Among Patients with Advanced Melanoma in the USA (MEMOIR): A Propensity Score-matched Analysis of a Single-centre, Longitudinal Study. Eur Urol. 2022 06; 81(6):623-624.

View in: PubMed
Ghosh AJ, Hobbs BD, Moll M, Saferali A, Boueiz A, Yun JH, Sciurba F, Barwick L, Limper AH, Flaherty K, Criner G, Brown KK, Wise R, Martinez FJ, Lomas D, Castaldi PJ, Carey VJ, DeMeo DL, Cho MH, Silverman EK, Hersh CP. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2022 02 01; 205(3):313-323.

View in: PubMed
Rizzo A, Mollica V, Santoni M, Ricci AD, Gadaleta-Caldarola G, Montironi R, Massari F. Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis. Future Oncol. 2022 Feb; 18(6):739-748.

View in: PubMed
Makker V, Colombo N, Casado Herr?ez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D. Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer. N Engl J Med. 2022 02 03; 386(5):437-448.

View in: PubMed
Liu J, Tio MC, Verma A, Schmidt IM, Ilori TO, Knauf F, Mc Causland FR, Waikar SS. Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease. J Clin Endocrinol Metab. 2022 01 01; 107(1):e281-e292.

View in: PubMed
Zhu X, Zou J, Mochel MC, Bledsoe JR. Reply to "Limitations of multivariate survival analysis". Mod Pathol. 2022 07; 35(7):994-995.

View in: PubMed

People

Explore

Similar Concepts

Top Journals